The cost-effectiveness of prostate cancer screening using the Stockholm3 test.

The cost-effectiveness of prostate cancer screening using the Stockholm3 test.

<h4>Objectives</h4>The European Randomized Study of Screening for Prostate Cancer found that prostate-specific antigen (PSA) screening reduced prostate cancer mortality, however the costs and harms from screening may outweigh any mortality reduction. Compared with screening using the PSA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andreas A Karlsson, Shuang Hao, Alexandra Jauhiainen, K Miriam Elfström, Lars Egevad, Tobias Nordström, Emelie Heintz, Mark S Clements
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/595dd50b114243c0aa3c321fc831be59
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares